Drugs / Osurdex
last change Oct 2011 re-read 2 minutes ago

Osurdex

Developed for
retinal vein occlusion

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01085734 Comparator Mar 2010 → Oct 2011 retinal vein occlusion Maturi, Raj K., M.D., P.C. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Osurdex ClinicalTrials.gov intervention name — accepted as the source's own label NCT01085734
Route Intravitreal “0.7mg intravitreally” NCT01085734